WELLINGTON MANAGEMENT GROUP LLP

Position in SVRA — Savara Inc

CIK 902219 Boston, MA

Position in SVRA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$14,800,546

-$1,329,287 QoQ

Shares Held

2,710,723

+1.3% QoQ

Ownership

1.32%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#19

of 184 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 74.16176422305045.ToString("F0")% None 25.838235776949542.ToString("F0")%

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $14,419,413,771 across 180 Biotechnology names. SVRA ranks #66 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,212,589	$1,434,549,489
2	REGN	Regeneron Pharmaceuticals, Inc.	1,837,459	$1,419,694,318
3	ARGX	Argenx SE	1,021,457	$745,918,971
4	ALNY	Alnylam Pharmaceuticals, Inc.	1,935,925	$640,539,501
5	RVMD	Revolution Medicines, Inc.	6,027,819	$586,205,394
6	CYTK	Cytokinetics Inc	8,009,489	$527,905,416
7	IONS	Ionis Pharmaceuticals Inc	6,391,816	$479,961,458
8	ASND	Ascendis Pharma A/S	1,757,633	$402,023,391

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,800,546	2,710,723	+1.3%	Shares	Defined	2026-05-15
2025-12-31	$16,129,833	2,674,931	+1.2%	Shares	Defined	2026-02-17
2025-09-30	$9,439,078	2,644,000	-21.1%	Shares	Defined	2025-11-14
2025-06-30	$7,638,617	3,350,272	-19.5%	Shares	Defined	2025-08-14
2025-03-31	$11,530,547	4,162,653	-24.1%	Shares	Defined	2025-05-13
2024-12-31	$16,828,676	5,481,654	-36.4%	Shares	Defined	2025-02-12
2024-09-30	$36,565,810	8,624,012	+22.9%	Shares	Defined	2024-11-14
2024-06-30	$28,272,421	7,015,490	+152.4%	Shares	Defined	2024-08-14
2024-03-31	$13,840,343	2,779,186	+34.9%	Shares	Defined	2024-05-15
2023-12-31	$9,682,812	2,060,173	—	Shares	Defined	2024-02-12
No filing history on record for this holder in this stock.